TWiV 1312: Daniel Griffin reviews CDC testing cuts, a rewritten ACIP charter, measles spread and COVID guidance.
A population-based Rochester Epidemiology Project cohort followed 4,721 people with EBV-positive mono against 14,163 matched controls, median follow-up six years for the exposed and eight for the reference. MS developed in 0.17% of the mono group versus 0.07%, a greater than threefold increased risk.
Answered around 12:56The 2025 IDSA guideline update recommends nirmatrelvir-ritonavir over no antiviral treatment for adults with mild to moderate COVID-19 at high risk, a strong recommendation. Table one covers age 75 and older, B-cell problems, hematological malignancies, HIV with CD4 under 200, and solid organ transplants.
Answered around 20:33No. If you wait and see, you wait too long. As with flu and other viral diseases, the window of opportunity to make a difference closes, so waiting until someone ends up in the hospital is too late. Step in as soon as possible.
Answered around 22:11Exposure studies suggested roughly one in every 10,000 cases had no explanation other than contact, so it happens but is very small. Virus can stay infectious a few days on surfaces, yet transmission needs contamination, pickup and delivery. Breathing it in is far more straightforward.
Answered around 34:50Hopkins data puts it at 1,768 cases already this year, with CDC counting 1,671, so roughly the same ballpark. This is local spread, not imported cases. The hotspot right now is Utah, South Carolina seems to have settled, and there is a cluster in southwestern Texas.
Answered around 15:10A ruling invalidated the panel for insufficient relevant expertise, so the charter was rewritten and published April 8th. Members must now be knowledgeable, not experts, and the listed fields are joined by or, so someone knowing only recovery from serious vaccine injuries could qualify.
Answered around 5:32After waiting three weeks and under protest, Raw Farm recalled its raw milk cheddar cheese products, linked to a multi-state E. coli outbreak that sickened nine people. The California company had refused, contesting the FDA's epidemiological links and calling them a false possible link and extreme allegations.
Answered around 9:43A Microbiology Spectrum study sampled healthy, influenza, moderate and severe COVID participants twice and found Dolosigranulum pigrum and Corynebacterium species less abundant in people who developed PASC. Antibiotic use was associated with lower levels of these key protective taxa, which may increase susceptibility to PASC on superinfection.
Answered around 27:48Ideally two to three weeks before an anticipated peak, so protection is in place as cases rise again in July and August. Antibody levels correlating with protection start dropping after about six months, and with two peaks a year, an eight-month then four-month spacing works.
Answered around 38:16Multiplexing, particularly with PCR, does have some impact on sensitivity, but the tests are designed so they still pick up flu A or B, COVID and RSV. Because these are lateral flow, really flowing across, the impact is not as bad.
Answered around 41:19“The problem arises when irrational thought and attendant behavior fill the vacuum left by ignorance.”
“Like when it works, you never hear about it.”
“In our new charter, you don't actually have to be an expert.”
“We 100% disagree with the FDA's false possible link and extreme allegations.”
“So it was greater than a threefold increased risk of MS in the folks that developed mono.”
“If you wait and see, you wait too long.”
“CDC Testing Cuts and ACIP Charter Change.” https://traffic.libsyn.com/secure/twiv/TWIV1312.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/cdc-testing-cuts-and-acip-charter-change.html.